Crinetics Pharmaceuticals Inc (CRNX) Insider Trading
- $45,793,090.74
- $89,789,073.23
- April 8, 2026
- Stephen F Betz
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 1, 2023 | CFO | 10,000 | $28.75 | Sell | $287,500.00 | |
| Oct. 17, 2023 | Insider | 7,000 | $30.00 | Sell | $210,000.00 | |
| July 13, 2023 | CEO | 14,157 | $20.35 | Sell | $288,094.95 | |
| July 11, 2023 | CEO | 24,384 | $20.14 | Sell | $491,093.76 | |
| June 20, 2023 | CFO | 30,922 | $19.97 | Sell | $617,512.34 | |
| June 16, 2023 | CEO | 50,000 | $20.81 | Sell | $1,040,500.00 | |
| June 8, 2023 | Director | 5,000 | $22.06 | Buy | $110,300.00 | |
| April 5, 2023 | Insider | 8,212 | $16.15 | Sell | $132,623.80 | |
| Jan. 25, 2023 | Insider | 8,336 | $21.07 | Sell | $175,639.52 | |
| Jan. 17, 2023 | Insider | 3,126 | $18.00 | Sell | $56,268.00 | |
| Dec. 15, 2022 | Insider | 3,126 | $16.00 | Sell | $50,016.00 | |
| Dec. 1, 2022 | Insider | 3,126 | $17.84 | Sell | $55,767.84 | |
| Nov. 15, 2022 | Insider | 3,126 | $18.72 | Sell | $58,518.72 | |
| Oct. 17, 2022 | Insider | 3,126 | $17.73 | Sell | $55,423.98 | |
| Oct. 3, 2022 | Insider | 3,126 | $19.64 | Sell | $61,394.64 | |
| Sept. 15, 2022 | Insider | 4,168 | $21.01 | Sell | $87,569.68 | |
| Sept. 7, 2022 | Insider | 1,042 | $21.00 | Sell | $21,882.00 | |
| July 26, 2022 | COO | 1,152 | $20.70 | Sell | $23,846.40 | |
| July 13, 2022 | Director | 5,700 | $20.96 | Sell | $119,472.00 | |
| July 13, 2022 | N/A | 5,700 | $20.96 | Sell | $119,472.00 | |
| May 2, 2022 | Insider | 3,247 | $20.10 | Sell | $65,264.70 | |
| April 18, 2022 | Insider | 5,664 | $25.81 | Sell | $146,187.84 | |
| April 18, 2022 | Major Shareholder | 157,515 | $22.22 | Buy | $3,499,983.30 | |
| April 13, 2022 | CEO | 138,643 | $26.83 | Sell | $3,719,791.69 | |
| April 5, 2022 | CEO | 21,357 | $25.34 | Sell | $541,186.38 | |
| April 4, 2022 | Insider | 9,000 | $23.97 | Sell | $215,730.00 | |
| March 31, 2022 | Insider | 4,164 | $21.06 | Sell | $87,693.84 | |
| March 1, 2022 | Insider | 3,123 | $19.73 | Sell | $61,616.79 | |
| Feb. 7, 2022 | Insider | 13,411 | $17.83 | Sell | $239,118.13 | |
| Feb. 1, 2022 | Insider | 3,123 | $18.79 | Sell | $58,681.17 | |
| Jan. 18, 2022 | Insider | 4,168 | $23.29 | Sell | $97,072.72 | |
| Jan. 3, 2022 | Insider | 7,168 | $28.02 | Sell | $200,847.36 | |
| Dec. 28, 2021 | Insider | 3,000 | $27.95 | Sell | $83,850.00 | |
| Dec. 15, 2021 | Insider | 5,668 | $24.14 | Sell | $136,825.52 | |
| Dec. 1, 2021 | Insider | 5,668 | $27.38 | Sell | $155,189.84 | |
| Nov. 8, 2021 | Insider | 3,900 | $28.42 | Sell | $110,838.00 | |
| Nov. 5, 2021 | Insider | 12,600 | $27.95 | Sell | $352,170.00 | |
| Nov. 1, 2021 | Director | 8,954 | $25.50 | Sell | $228,327.00 | |
| Nov. 1, 2021 | Insider | 5,668 | $24.79 | Sell | $140,509.72 | |
| Oct. 27, 2021 | Insider | 3,000 | $24.00 | Sell | $72,000.00 | |
| Oct. 25, 2021 | Major Shareholder | 1,200,000 | $19.80 | Buy | $23,760,000.00 | |
| Oct. 21, 2021 | Insider | 1,042 | $21.10 | Sell | $21,986.20 | |
| Sept. 8, 2021 | Director | 6,046 | $25.50 | Sell | $154,173.00 | |
| Sept. 7, 2021 | CEO | 30,000 | $25.00 | Sell | $750,000.00 | |
| July 26, 2021 | Director | 5,000 | $19.59 | Sell | $97,950.00 | |
| July 19, 2021 | Director | 5,000 | $19.50 | Sell | $97,500.00 | |
| July 12, 2021 | Director | 5,000 | $20.71 | Sell | $103,550.00 | |
| April 8, 2021 | Major Shareholder | 304,136 | $16.44 | Buy | $4,999,995.84 | |
| Dec. 2, 2020 | CEO | 1,000 | $12.60 | Buy | $12,600.00 | |
| July 15, 2020 | CEO | 17,500 | $15.30 | Sell | $267,750.00 |
Insiders are both buying and selling Crinetics Pharmaceuticals Inc stock.
The insider traders at Crinetics Pharmaceuticals Inc are: Stephen F Betz, Richard Scott Struthers, Dana Pizzuti, Vivo Capital Viii, Llc, Matthew K Fust, Jeff E Knight, Marc Wilson, Perceptive Advisors Llc, Ventures Iv L.P. 5Am, Coelho Rogerio Vivaldi, James Hassard, Alan Seth Krasner, Stephanie Okey, Vivo Capital Fund Viii, L.P., Ajay Madan, Fust Matthew K, Tobin Schilke, and Life Sciences Maste Perceptive
The most active insider trader at Crinetics Pharmaceuticals Inc is Stephen F Betz with 39 trades.
Richard Scott Struthers has sold the most Crinetics Pharmaceuticals Inc stock with a total value of $22,739,674.11.
Perceptive Advisors Llc has bought the most Crinetics Pharmaceuticals Inc stock with a total value of $35,759,962.44.
The most recent insider trade for Crinetics Pharmaceuticals Inc was on April 8, 2026.
The single biggest insider buy for Crinetics Pharmaceuticals Inc was from Perceptive Advisors Llc with a total value of $23,760,000.00 on Oct. 25, 2021.
The single biggest insider sell for Crinetics Pharmaceuticals Inc was from Vivo Capital Fund Viii, L.P. with a total value of $9,278,250.00 on March 20, 2019.
